Lurasidone as a potential therapy for bipolar disorder

Lurasidone is a benzisothiazol derivative and an atypical antipsychotic approved by the US Food and Drug Administration for the acute treatment of adults with schizophrenia (October 2010) and bipolar 1 depression (June 2013). Lurasidone has a strong antagonistic property at the D(2), serotonin (5-HT...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Young Sup, Wang, Hee Ryung, Bahk, Won-Myong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797281/
https://www.ncbi.nlm.nih.gov/pubmed/24143101
http://dx.doi.org/10.2147/NDT.S51910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797281/
https://www.ncbi.nlm.nih.gov/pubmed/24143101
http://dx.doi.org/10.2147/NDT.S51910

Ejemplares similares